Published in J Anal Toxicol on October 01, 2004
Long-term cognitive impairment after critical illness. N Engl J Med (2013) 9.20
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A (1985) 4.76
Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem (1989) 2.42
Character and duration of pharmacological effects of intravenous isoxsuprine. Equine Vet J (1996) 1.93
Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells. J Cell Biol (1985) 1.88
Changing patterns of plasma membrane-associated filaments during the initial phases of polymorphonuclear leukocyte adherence. J Cell Biol (1979) 1.67
Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med (2013) 1.62
Flexibility of an active center in sodium-plus-potassium adenosine triphosphatase. J Gen Physiol (1969) 1.55
Pericytes, like vascular smooth muscle cells, are immunocytochemically positive for cyclic GMP-dependent protein kinase. Microvasc Res (1984) 1.48
The dental caries experience of 5-year-old children in Great Britain (2005/6). Surveys co-ordinated by the British Association for the study of community dentistry. Community Dent Health (2007) 1.43
Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J (1997) 1.40
Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J Ultrastruct Res (1983) 1.30
Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology (1992) 1.28
The dental caries experience of 11-year-old children in Great Britain. Surveys coordinated by the British Association for the Study of Community Dentistry in 2004 / 2005. Community Dent Health (2006) 1.28
A cycle for ouabain inhibition of sodium- and potassium-dependent adenosine triphosphatase. J Biol Chem (1969) 1.26
Changes in plasma-membrane-associated filaments during endocytosis and exocytosis in polymorphonuclear leukocytes. Cell (1981) 1.26
The clinical diagnosis of Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol (1967) 1.20
Activation of alveolar macrophages after lower respiratory tract infection. J Immunol (1975) 1.18
Organization of the cytoskeleton in resting, discoid platelets: preservation of actin filaments by a modified fixation that prevents osmium damage. J Cell Biol (1985) 1.16
Yersinia pestis: correlation of ultrastructures and immunological status. Infect Immun (1975) 1.15
A new fixative for the preservation of actin filaments: fixation of pure actin filament pellets. J Histochem Cytochem (1985) 1.14
Stability and ligand sensitivity of (3H)ouabain binding to (Na+ + K+)ATPase. Biochim Biophys Acta (1970) 1.14
Calcium ion and sodium- and potassium-dependent adenosine triphosphatase: its mechanism of inhibition and identification of the E 1 -P intermediate. Mol Pharmacol (1973) 1.13
Tramadol for osteoarthritis. Cochrane Database Syst Rev (2006) 1.03
Rates of dissociation of enzyme-ouabain complexes and K 0.5 values in (Na + + K + ) adenosine triphosphatase from different species. Biochem Pharmacol (1972) 1.01
Recovery of procaine from biological fluids. Res Commun Chem Pathol Pharmacol (1975) 0.95
The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages. J Cell Biol (1991) 0.94
Dose-related effects of ethylketazocine on nociception, behaviour and autonomic responses in the horse. J Pharm Pharmacol (1986) 0.93
A method for studying cutaneous pain perception and analgesia in horses. J Pharmacol Methods (1985) 0.90
Uptake of apolipoprotein E-containing high density lipoproteins by hepatic parenchymal cells. Arteriosclerosis (1984) 0.90
Genetic analysis of sensitization and tolerance to cocaine. J Pharmacol Exp Ther (1994) 0.89
Comparative species studies on the effect of monovalent cations and ouabain on cardiac Na+, K+-adenosine triphosphatase and contractile force. J Pharmacol Exp Ther (1976) 0.88
Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K + )- activated ATPase. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.88
Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice. J Inherit Metab Dis (2000) 0.88
Evidence for surface entrapment of cholesterol-rich lipoproteins in luteinized ovary. Arteriosclerosis (1988) 0.88
Lithium and rubidium interactions with sodium- and potassium-dependent adenosine triphosphatase: a molecular basis for the pharmacological actions of these ions. Mol Pharmacol (1974) 0.87
L-Canavanine, a Dietary Nitrogen Source for the Seed Predator Caryedes brasiliensis (Bruchidae). Science (1982) 0.87
Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings. J Vet Pharmacol Ther (1998) 0.87
Ouabain binding to (Na+ plus K+)-ATPase. Effects of nucleotide analogues and ethacrynic acid. Biochim Biophys Acta (1974) 0.87
The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse. J Vet Pharmacol Ther (1982) 0.86
Characterization of the antinociceptive and sedative effect of amitraz in horses. J Vet Pharmacol Ther (1998) 0.86
Mepivacaine: its pharmacological effects and their relationship to analytical findings in the horse. J Vet Pharmacol Ther (1999) 0.86
The dental caries experience of 5-year-old children in England and Wales (2003/4) and in Scotland (2002/3). Surveys co-ordinated by the British Association for the Study of Community Dentistry. Community Dent Health (2005) 0.86
Bupivacaine in the horse: relationship of local anaesthetic responses and urinary concentrations of 3-hydroxybupivacaine. J Vet Pharmacol Ther (1999) 0.86
Narcotic analgesics, their detection and pain measurement in the horse: a review. Equine Vet J (1989) 0.84
Cassaine: mechanism of inhibition of Na+ +K+ -ATPase and relationship of this inhibition to cardiotonic actions. Eur J Pharmacol (1975) 0.84
Factors and agents that influence cardiac glycoside-Na+, K+-ATPase interaction. Ann N Y Acad Sci (1974) 0.83
Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats. Res Commun Chem Pathol Pharmacol (1972) 0.83
Dose related effects of the kappa agonist U-50, 488H on behaviour, nociception and autonomic response in the horse. Equine Vet J (1988) 0.83
Phenylbutazone in the horse: a review. J Vet Pharmacol Ther (1986) 0.83
Species and tissue differences in the rate of dissociation of ouabain from (Na+ + K+)-ATPase. Biochim Biophys Acta (1972) 0.82
Morphine glucuronide hydrolysis: superiority of beta-glucuronidase from Patella vulgata. Clin Chem (1982) 0.81
Pharmacokinetics and distribution of diphenylhydantoin in kittens. Am J Vet Res (1973) 0.81
Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse. Equine Vet J (1990) 0.81
Dose-related effects of fentanyl on autonomic and behavioral responses in performance horses. Gen Pharmacol (1985) 0.81
Pseudoleucocytosis and pseudothrombocytosis due to cryoglobulinaemia. J Clin Pathol (1987) 0.80
The complexes of ouabain with sodium- and potassium-activated adenosine triphosphatase formed with various ligands: relationship to the complex formed in the beating heart. Mol Pharmacol (1976) 0.80
Studies on the two phosphoenzyme conformations of Na+ plus K+-ATPase. Ann N Y Acad Sci (1974) 0.80
Determination of highest no effect dose (HNED) for local anaesthetic responses to procaine, cocaine, bupivacaine and benzocaine. Equine Vet J (1996) 0.79
Allosteric interactions in (Na+ plus K+)-ATPase. Nature (1970) 0.79
Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics. J Vet Pharmacol Ther (1999) 0.79
Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology (1992) 0.78
Detomidine: a preliminary analysis of its duration of action in the horse by variable interval responding. Equine Vet J (1988) 0.78
Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA. Braz J Med Biol Res (2001) 0.78
Differential effects of phenylbutazone and local anesthetics on nociception in the equine. Eur J Pharmacol (1984) 0.78
Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats. J Vet Intern Med (2014) 0.78
Showdomycin, a nucleotide-site-directed inhibitor of (Na+ + K+)-ATPase. Biochim Biophys Acta (1975) 0.78
Development and characterization of an equine behaviour chamber and the effects of amitraz and detomidine on spontaneous locomotor activity. J Vet Pharmacol Ther (1997) 0.78
Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses. Am J Vet Res (1983) 0.78
Pyrilamine in the horse: detection and pharmacokinetics of pyrilamine and its major urinary metabolite O-desmethylpyrilamine. J Vet Pharmacol Ther (2009) 0.78